{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "NOK", "exchange": "OSL", "shortName": "GENTIAN DIAGNOSTICS ASA", "longName": "Gentian Diagnostics ASA", "messageBoardId": "finmb_413765020", "exchangeTimezoneName": "Europe/Oslo", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "no_market", "esgPopulated": false, "regularMarketChangePercent": -3.846152, "regularMarketPrice": 45.0, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.09819642, "fiftyTwoWeekLow": 35.0, "fiftyTwoWeekHigh": 49.9, "earningsTimestamp": 1634813940, "earningsTimestampStart": 1644577140, "earningsTimestampEnd": 1644840000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.15, "epsForward": -0.54, "epsCurrentYear": -0.86, "priceEpsCurrentYear": -52.32558, "sharesOutstanding": 15422400, "bookValue": 9.997, "fiftyDayAverage": 41.698, "fiftyDayAverageChange": 3.3019981, "fiftyDayAverageChangePercent": 0.0791884, "twoHundredDayAverage": 41.182, "twoHundredDayAverageChange": 3.8180008, "twoHundredDayAverageChangePercent": 0.09271043, "marketCap": 694008000, "forwardPE": -83.33333, "priceToBook": 4.5013504, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Gentian Diagnostics AS", "nameChangeDate": "2023-05-14", "averageAnalystRating": "1.0 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": -1.7999992, "regularMarketTime": 1684138238, "regularMarketDayHigh": 45.1, "regularMarketDayRange": "45.0 - 45.1", "regularMarketDayLow": 45.0, "regularMarketVolume": 3100, "regularMarketPreviousClose": 46.8, "bid": 40.5, "ask": 45.1, "fullExchangeName": "Oslo", "financialCurrency": "NOK", "regularMarketOpen": 45.0, "averageDailyVolume3Month": 7235, "averageDailyVolume10Day": 961, "fiftyTwoWeekLowChange": 10.0, "fiftyTwoWeekLowChangePercent": 0.2857143, "fiftyTwoWeekRange": "35.0 - 49.9", "fiftyTwoWeekHighChange": -4.9000015, "firstTradeDateMilliseconds": 1481702400000, "symbol": "GENT.OL"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Bj\u00f8rn\u00e5sveien 5", "city": "Moss", "zip": "1596", "country": "Norway", "phone": "47 99 33 99 05", "website": "https://www.gentian.com", "industry": "Medical Devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research in Europe, Asia, and the United States. It offers in-vitro diagnostic reagents for clinical chemistry analyzers. The company's products include the gentian calprotectin immunoassay, a turbidimetric immunoassay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Cystatin C, a superior GFR marker for the diagnosis and therapeutic control of renal function; NT-proBNP Immunoassay for diagnosis, monitoring, and assessment of severity in individuals suspected of having congestive heart failure; and Canine c-reactive protein (CRP) immunoassay, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine CRP in dog plasma and serum. It also provides turbidimetric SARS-CoV-2 total antibody immunoassay, a quantitative antibody test for detecting antibodies targeting the S1-subunit. Gentian Diagnostics ASA was incorporated in 2001 and is headquartered in Moss, Norway.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Hilja  Ibert", "title": "Chief Exec. Officer", "fiscalYear": 2022, "totalPay": {"raw": 3463000, "fmt": "3.46M", "longFmt": "3,463,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Njaal  Kind", "title": "CFO & COO", "fiscalYear": 2022, "totalPay": {"raw": 2371000, "fmt": "2.37M", "longFmt": "2,371,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Markus  Jaquemar", "title": "VP of Global Sales", "fiscalYear": 2022, "totalPay": {"raw": 2103000, "fmt": "2.1M", "longFmt": "2,103,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Aleksandra  Havelka", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ingo  Curdt", "title": "Head of Innovation & Research", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tom  Nilsen", "title": "Head of Product Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}